Ginsenoside ameliorated ventilator-induced lung injury in rats
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- JOURNAL OF INTENSIVE CARE8(1) · 2020
- 피인용
- Web of Science 15Scopus 16
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 3.103
- ISSN
- 2052-0492
저자
- 조우현제1저자Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Geumo-ro 20, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do, 626-770, Republic of Korea
- 김윤학Department of Anatomy and Department of Biomedical Informatics, School of Medicine, Pusan National University, Busan, Republic of Korea
- 허혜진Department of Anatomy and Department of Biomedical Informatics, School of Medicine, Pusan National University, Busan, Republic of Korea
- 김도형Department of Thoracic and Cardiovascular surgery, Pusan National University Yangsan Hospital, Yangsan-si, Republic of Korea
- Kwak, Tae WonMedical Convergence Materials Commercialization Center, GyeongBuk TechnoPark, Gyeongbuk, Republic of Korea
- Kim, Kwang HoMedical Convergence Materials Commercialization Center, GyeongBuk TechnoPark, Gyeongbuk, Republic of Korea
- 여혜주교신저자Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Geumo-ro 20, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do, 626-770, Republic of Korea
초록
BackgroundGinsenosides have antioxidant and anti-inflammatory features. This study aimed to evaluate the biologic effects of ginsenoside Rb2 pretreatment on ventilator-induced lung injury (VILI) in rats.MethodsRats were divided into four groups with 12 rats per group: control; low tidal volume (TV), TV of 6mL/kg, VILI, TV of 20mL/kg, positive end-expiratory pressure of 5cm H2O, and respiratory rate of 60 breaths per minute for 3h at an inspiratory oxygen fraction of 0.21; and ginsenosides, treated the same as the VILI group but with 20mg/kg intraperitoneal ginsenoside pretreatment. Morphology was observed with a microscope to confirm the VILI model. Wet-to-dry weight ratios, protein concentrations, and pro-inflammatory cytokines in the bronchoalveolar lavage fluid were measured. RNA sequencing of the lung tissues was conducted to analyze gene expression.ResultsHigh TV histologically induced VILI with alveolar edema and infiltration of inflammatory cells. Ginsenosides pretreatment significantly reduced the histologic lung injury score compared to the VILI group. Wet-to-dry weight ratios, malondialdehyde, and TNF-alpha in bronchoalveolar lavage fluid were significantly higher in the VILI group and ginsenoside pretreatment mitigated these effects. In the immunohistochemistry assay, ginsenoside pretreatment attenuated the TNF-alpha upregulation induced by VILI. We identified 823 genes differentially presented in the VILI group compared to the control group. Of the 823 genes, only 13 genes (Arrdc2, Cygb, Exnef, Lcn2, Mroh7, Nsf, Rexo2, Srp9, Tead3, Ephb6, Mvd, Sytl4, and Ube2l6) recovered to control levels in the ginsenoside group.ConclusionsGinsenosides inhibited the inflammatory and oxidative stress response in VILI. Further studies are required on the 13 genes, including LCN2.
키워드
GinsenosidesVentilator-induced lung injuryTumor necrosis factor-alphaLCN2NGALNF-KAPPA-BPANAX-GINSENGTRANSCRIPTIONAL ACTIVITYINFLAMMATIONINHIBITIONSUPPRESSESMECHANISMSEXPRESSIONINDUCTIONHEPG2
식별자
- Scopus EID
- 2-s2.0-85096432590
- WoS UID
- 000595881000004



로그인
연구물 목록으로